Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-COPD: Titrated vs Standard Oxygen Therapy in Prehospital AECOPD
NCT05703919Phase 4Recruiting
- Sponsor
- Central Denmark Region
- Start
- Jun 2025
- Primary completion
- Feb 2028
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of oxygen in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Central Denmark Region. Primary endpoint: Mortality, 30-day. Started Jun 2025; status: recruiting.
02
Drugs
oxygen
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05703919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05703919.